Your browser doesn't support javascript.
loading
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.
van Berge Henegouwen, J M; van der Wijngaart, H; Zeverijn, L J; Hoes, L R; Meertens, M; Huitema, A D R; Devriese, L A; Labots, M; Verheul, H M W; Voest, E E; Gelderblom, H.
Afiliação
  • van Berge Henegouwen JM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Wijngaart H; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Zeverijn LJ; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Hoes LR; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Meertens M; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Huitema ADR; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Devriese LA; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Labots M; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Verheul HMW; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Voest EE; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Gelderblom H; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Cancer Chemother Pharmacol ; 90(1): 97-104, 2022 07.
Article em En | MEDLINE | ID: mdl-35598186
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperidinas / Neoplasias Cutâneas / Azetidinas / Neoplasias da Glândula Tireoide / Vemurafenib / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperidinas / Neoplasias Cutâneas / Azetidinas / Neoplasias da Glândula Tireoide / Vemurafenib / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda